Welzenbach Mark Joseph
Known title: Executive Vice PresidentCIK: 0001576903
Associated companies
Transaction History
| THG | ▼ Sell | Tax Withholding | 37 | $5K | 12/31/2022 | View on chart |
| THG | ▲ Buy | Grant | 19 | $0 | 12/30/2022 | View on chart |
| THG | ▼ Sell | Open Market | 2,673 | $380K | 11/4/2022 | View on chart |
| THG | ▲ Buy | Grant | 18 | $0 | 9/30/2022 | View on chart |
| THG | ▲ Buy | Grant | 16 | $0 | 6/24/2022 | View on chart |
| THG | ▲ Buy | Grant | 16 | $0 | 3/25/2022 | View on chart |
| THG | ▼ Sell | Tax Withholding | 1,077 | $150K | 3/7/2022 | View on chart |
| THG | ▲ Buy | Grant | 1,672 | $0 | 2/28/2022 | View on chart |
| THG | ▲ Buy | Grant | 936 | $0 | 2/28/2022 | View on chart |
| THG | ▲ Buy | Grant | 896 | $0 | 2/28/2022 | View on chart |
| THG | ▲ Buy | Option Exercise | 10,377 | $1.1M | 2/4/2022 | View on chart |
| THG | ▼ Sell | Open Market | 10,377 | $1.4M | 2/4/2022 | View on chart |
| THG | ▲ Buy | Option Exercise | 4,686 | $549K | 2/4/2022 | View on chart |
| THG | ▼ Sell | Open Market | 4,686 | $658K | 2/4/2022 | View on chart |
| THG | ▲ Buy | Grant | 19 | $0 | 12/30/2021 | View on chart |
| THG | ▲ Buy | Grant | 17 | $0 | 9/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Hanover Insurance (THG) Draws Attention for Growth and Valuation
Recent articles highlight Hanover Insurance as a potential growth candidate, citing strong capital allocation and a discounted valuation. These reports suggest the stock may be undervalued relative to its fundamentals. The company is currently trading near its 52-week high, with an average analyst target price of $235.88.
Hanover Insurance (THG) Draws Attention for Growth and Valuation. Recent articles highlight Hanover Insurance as a potential growth candidate, citing strong capital allocation and a discounted valuation. These reports suggest the stock may be undervalued relative to its fundamentals. The company is currently trading near its 52-week high, with an average analyst target price of $235.88.